Covagen
	Operator of a biopharmaceutical company focused on therapies for inflammatory diseases and cancer. The company provides a proprietary platform that genetically fuses Fynomer binding proteins to antibodies, resulting in therapeutics with novel modes of action. The company’s first clinical drug candidate is designed for treatment of rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases.
	['', 'inflammation binder', ' ', 'protein therapy', ' ', 'clinical drug', '']
Cartesia Dx
	Developer of thermal/3D imaging system to quantify inflammation and to diagnose and manage rheumatoid arthritis. The company\'s technology also quantifies assessment of swelling and warmth in various diseases.
	['', '3D imaging system', ' ', 'thermal imaging system', ' ', 'rheumatoid arthritis treatment', '']
Merrimack Pharmaceuticals
	Provider of commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The company develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor.
	['', 'commercial medicine', ' ', 'diagnostic treatment', ' cancer']
Domantis
	Developer of antibody molecules for therapy. It offers dual targeting human domain antibodies, which are used against cytokine targets for inflammatory diseases, tumour antigens present on the same tumour cells, and tumour growth/angiogenic factors for solid tumours; human domain antibodies with tailored serum half-life that are customized to achieve the desired therapeutic effect; human domain antibodies for diverse therapeutic targets, which are suited to inhibit receptor targets; and injectable and non-injectable human domain antibodies that treat diseases of the lung, as well as disorders of the gastro-intestinal tract.
	['', 'antibody therapeutic', ' ', 'domain antibody', ' ', 'antibody molecules', ' ', 'antibody molecules for therapy', ' ', 'dual targeting human domain antibodies', ' ', 'human domain antibodies', ' ', 'disease therapy', ' ', 'tumor therapy', ' ', 'disease therapy', '']
BG Medicine
	Developer of novel cardiovascular diagnostic tests. The company\'s product pipeline includes BGM Galectin-3, a diagnostic test for heart failure that measures galectin-3 levels in blood plasma or serum. It also offers TNF alpha blockers comprising Enbrel, Remicade and Humira, which are treatments indicated for autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease.
	['', 'diagnostic test', ' ', 'heart failure', ' ', 'cardiovascular test', ' ', 'lipid disorder', '']
Plant Genetic Systems
	Developer of genetically engineered plants. The company is a biotech company lacated in Ghent, Belgium. The was the first (in 1985) to develop genetically engineered (tobacco) plants with insect tolerance by expressing genes encoding for insecticidal proteins from Bacillus thuringiensis (Bt).
	['', 'genetic engineering', ' ', 'plants', ' ', 'insecticidal protein', '']
Immunex
	Provider of biopharmaceutical drug discovery. The company is focused on immune-system research, in the disciplines of immunology, cytokine biology, vascular biology, antibody-based therapeutics and small-molecule research. It works to develop new therapeutics for rheumatoid arthritis, asthma and other inflammatory diseases, as well as cancer and cardiovascular diseases.
	['', 'antibody therapeutics', ' ', 'vascular science', ' ', 'rheumatoid arthritis', ' asthma ', 'cardiovascular therapy', '']
